Pfizer scraps daily weight loss pill danuglipron after a liver injury
Kena Betancur | Corbis News | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said … Read more